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Abstract 
Background. Ultrafiltration failure (UFF) diagnosed at the initiation of peritoneal dialysis (PD) has been 
insufficiently characterized. In particular, few longitudinal studies have analyzed the time course of water 
transport in patients with this complication. 
Objective. To investigate the time course of peritoneal water transport during the first year on PD in patients 
presenting UFF since the initiation of this therapy (study group). 
Method. Prospective, observational, single-center design. We analyzed, at baseline and after 1 year of follow-
up, peritoneal water transport in 19 patients incident on PD with UFF. We used incident patients without UFF 
as a control group. Water transport was characterized with the help of 3.86/4.25% dextrose-based peritoneal 
equilibration tests (PETs) with complete drainage at 60 minutes. 
Results. The study group revealed a disorder of water transport affecting both small-pore ultrafiltration 
(SPUF) (p = 0.054 vs incident without UFF) and free water transport (FW T) (p = 0.001). After 1 year of 
follow-up, FWT displayed a general increasing trend in the study group (mean variation 48.9 mL, 95% 
confidence interval [CI] 15.5, 82.2, p = 0.012), while the behavior of SPUF was less predictable (-4.8 mL, 
95% CI -61.4, 71.1, p = 0.85). These changes were not observed in incident patients without UFF. Neither 
initial clinical characteristics, baseline PET-derived parameters, or suffering peritoneal infections during the 
first year predicted the time course of the capacity of UF in the study group. Recovery from incident UFF was 
apparently linked to improvement of SPUF. 
Conclusions. Patients with UFF at the start of PD suffer a disorder of peritoneal water transport affecting both 
FWT and SPUF. Free water transport increases systematically in these patients after 1 year of follow-up. The 
evolution of SPUF is less predictable, and improvement of this parameter marks reversibility of this 
complication. 
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Failure to obtain adequate rates of ultrafiltration (UF) is one of the most feared complications of 
peritoneal dialysis (PD), resulting in recurrent or persistent volume overload, with well-known 
detrimental consequences for the cardiovascular outcome of these patients (1). Insufficient UF 
may be secondary to different causes, including mechanical complications and inadequate 
prescription of PD, but, in the majority of cases, it is the consequence of an intrinsic disorder of 
the peritoneal membrane, which prevents sufficient and/or sustained water transport toward the 
peritoneal cavity. The incidence and prevalence of UF failure (UFF) have not been established 
with certainty (2), partly due to a lack of a standardized definition of this complication until 
relatively recent years (3). Clinically significant UFF is, in the majority of cases, a relatively late 
complication of PD, appearing in response to chronic injury to the peritoneal membrane, 
precipitated by the bioincompatibility of PD solutions and by peritoneal infections, among other 
factors. This type of UFF indicates a deep structural disorder of the membrane, is essentially 
nonreversible, and contributes much to mortality and technique failure in long-term PD patients 
(4). On the other hand, some patients present features consistent with UFF from the initiation of 
PD. This complication is usually less consequential than late UFF, because residual kidney 
function helps to prevent hypervolemia. The mechanisms underlying early UFF are not totally 
clear, although it has been hypothesized that a large peritoneal vascular surface and fast lymphatic 
reabsorption rates play significant roles. It would appear that incident UFF has a potential for 
reversibility in a significant proportion of cases (5). 
 
The classic peritoneal equilibration test (PET), as designed for Twardowski (6), is not suitable for 
characterizing peritoneal water transport, which has hampered knowledge about this phenomenon 
in the past. Several functional tests have been proposed to overcome this limitation, including 
variants of the classic PET and more complex procedures, such as the peritoneal dialysis capacity 
(PDC) or the standard peritoneal assessment (SPA) tests (7). The modified PET with complete 
drainage at 60 minutes, based on 3.86/4.25% dextrose-based dialysate, permits a relatively 
accurate calculation of water transport during the first 60 minutes of a peritoneal exchange, 
allowing split estimations of transport across ultrasmall (free water transport [FWT]) and small 
pores (SPUF) (8,9). To our knowledge, this test has not been applied to assess peritoneal water 
transport longitudinally, either in PD patients in general or in those suffering from UFF. 
 
We performed a prospective, observational study with the main objective of investigating the time 
course of peritoneal water transport in a sample of patients incident on PD during a 1-year follow-
up period. Our main focus was to assess the evolution of incident patients presenting UFF since 
the initiation of PD. 
Method 
General Design 
Following a prospective, observational design, we investigated the time course of water transport 
in a group of patients incident on PD in the University Hospital of A Coruña (Spain), according to 
the results of 3.86/4.25% dextrose-based PET with complete abdominal emptying at 60 minutes. 
The recruitment period was from January 2009 to October 2013, and follow-up was closed by 
December 2014. The main objective of the study was to characterize the evolution of water 
transport over a period of 1 year, focusing on incident patients with UFF at baseline, comparing 
them with incident patients without UFF. 
 
The study complied with the requirements of the ethical committee of our center for observational 
studies, and oral consent for clinical data management was obtained from participants. 
  
Patients 
The study population included all patients incident on PD during the recruitment period. We 
considered the following inclusion criteria: 
 
– Age 15 – 85 years 
– Baseline and follow-up clinical records available 
– Expected survival of at least 1 year 
– PET data available at baseline and after 1 year of follow-up 
– No episode of peritonitis, hemoperitoneum, or abdominal surgery for at least 8 weeks 
before PET studies 
– Informed consent given 
 
We screened 72 patients during the recruitment period, but only 52 were finally included for 
analysis. The remaining patients did not fulfill the 1-year protocol, due to death (n = 4), kidney 
transplant (n = 7), drop-out to hemodialysis (n = 3), or other reasons (including protocol breaks or 
loss to follow-up) (n = 6). 
Strategy of Analysis 
The main objective of the study was to characterize the time course of UF and water transport of 
incident patients with UFF, which we defined according to the International Society for Peritoneal 
Dialysis (ISPD) recommendations (< 400 mL at 240 minutes during a 3.86/4.25% dextrose-based 
PET) (3). We compared this time course with those of a control group of incident patients without 
UFF. For this purpose, we first compared the clinical and peritoneal functional characteristics (as 
assessed from PET) of the 2 groups, and then the time course of the latter between the baseline and 
the follow-up PET. Finally, we focused on incident patients with UFF, comparing patients with 
transient and persistent UFF at the end of follow-up. General categorization of peritoneal transport 
was carried out according to the dialysate to plasma ratio (D/P) of creatinine at 240 minutes, as 
classically described by Twardowski (6). 
Pet Procedure 
After an overnight dwell with 2.27/2.5% dextrose-based dialysate, PET studies started at 9 a.m. 
We used 3.86/4.25% dextrose-based solutions of the same brand usually prescribed for the patient. 
The dialysate volume was that usually used by the patient, with an upper limit of 2 liters. After 
dialysate infusion, a partial drainage was immediately allowed, and a 10-mL sample was obtained 
for laboratory estimations. We allowed complete dialysate drainage at 60 and 240 minutes, to 
estimate UF and obtain new dialysate samples for laboratory estimations. Blood samples were 
obtained at baseline. Dialysate bags were weighed before infusion, at 60 minutes, and at 240 
minutes, to estimate UF. The baseline PET was performed not earlier than 4 weeks and not later 
than 12 weeks after initiation of PD. 
Laboratory Methods and Secondary Calculations 
Glucose, creatinine, and sodium (Na) were measured in both plasma and dialysate using standard 
automated analyzer techniques. Dialysate creatinine was corrected for interference by glucose 
according to our own laboratory standards. Sodium in dialysate and plasma was measured using an 
indirect ion selective electrode method. Sodium removal and peritoneal glucose loads were 
estimated by simple mass balance.  
We estimated the following parameters: 
 
– Sodium sieving, as the absolute dip of dialysate sodium concentration at 60 minutes, calculated as 
follows: 
 
Na sieving (mmol/L) = dialysate Na at 0' –dialysate Na at 60’ 
Na sieving (mmol/L) = dialysate Na at 0' –dialysate Na at 60’Na sieving (mmol/L) =   
 
– SPUF at 60’ was calculated as follows: 
 
SPUF (mL) = (NaR × 1,000) / PNa, 
SPUF (mL) = (NaR × 1,000) / PNa,SPUF (mL) = (NaR × 1,000) / PNa,  
where NaR (mmol) is Na removal and PNa is plasma sodium concentration (mM/L). Sodium 
removal was calculated as follows: 
 
NaR = [dialysate volume at 60' (L) × dialysate Na concentration at 60' (mmol/L)] –
 [dialysate volume instilled (L) × dialysate Na concentration at 0' (mmol/L)]. 
NaR = [dialysate volume at 60' (L) × dialysate Na concentration at 60' (mmol/L)] – [   
 
– FWT was calculated as follows: 
 
FWT uncorrected (mL) = total UF volume at 60' (mL) – SPUF(mL). 
FWT uncorrected (mL) = total UF volume at 60' (mL) – SPUF(mL).FWT ).  
 
– We also estimated corrected FWT, according to the algorithm described by Venturoli et al. (10): 
 
FWT corrected = total UF at 60' +15 −0.92× SPUF, where ''15'' represents tentative cumu
lative lymphatic absorption during 60 minutes (18 mL) minus the cumulative UF throug
h the large pores over 60 minutes (approx. 3 mL).FWT corrected = total UF at 60' +15 −
0.92× SPUF, where ″15″ represents tentative cumulative lymphatic absorption during 60 
minutes (18 mL) minus the cumulative UF through the large pores over 60 minutes (appr
ox. 3 mL). 
 
– Small solute transport characteristics were estimated from D/P of creatinine and D/D0 of glucose 
at 240’, as described by Twardowski (6). 
 
Data Analysis 
Numerical variables are presented as mean values (standard deviation [SD]), unless abnormally 
distributed (median with range). Categorical variables are presented as n (%). Comparisons were 
performed according to Student's t-test (paired and unpaired), χ2 distribution and nonparametric 
tests (Mann Whitney, Wilcoxon). 
Results 
Baseline 
Table 1 presents the baseline clinical characteristics of the study population. Patients with UFF 
were younger and tended to present higher levels of C-reactive protein than those without UFF. 
All patients were managed with low-glucose degradation product (GDP) solutions. Table 2 shows 





Variations between First and Second Pet 
When patients were reassessed after 1 year, 8 out of 19 patients (42.1%) with baseline UFF 
presented an UF at 240 minutes ≥ 400 mL, while UFF persisted in 11 (57.9%). Only 5 patients 
without UFF at baseline (15.2%) presented UFF after 1 year. Table 3 displays the time course of 
transport characteristics between baseline and follow-up PET studies. Incident patients with UFF 
experienced a significant increase in their UF capacity, based on an improvement in FWT, while 
SPUF did not change overall. On the contrary, patients without UFF at initiation of PD did not 
experience significant changes during the follow-up period. 
 
In patients with UFF, a comparison of baseline characteristics between those who improved their 
UF capacity 1 year later and those who did not showed that the latter tended to use icodextrin more 
frequently from baseline (81.8% vs 37.5%, p = 0.048 χ2) (age, diabetes, glomerular filtration rate 
[GFR], renin-angiotensin antagonists [RAA], C-reactive protein, and peritoneal glucose load were 
not significant). Moreover, baseline peritoneal transport characteristics did not differ significantly 
between the 2 subgroups (Table 4). Four out of 11 patients (36.4%) in whom UFF persisted 
suffered peritonitis between the baseline and the second PET, as compared with 3 of the 8 patients 
(37.5%) who improved their UF capacity (p = 0.68). Table 5 compares the time course of 
peritoneal transport characteristics in these 2 subgroups. The main difference affected SPUF, 
which increased in patients improving their UF capacity, with an opposite (not significant) trend 
for those with persistent UFF. Interestingly, FWT tended to improve in both groups, although to a 









According to our results, patients presenting with UFF at initiation of PD suffered a disorder of 
peritoneal water transport affecting both SPUF and FWT (Table 2). On reevaluation 1 year later, a 
trend to a general improvement of FWT was observed, while the evolution of SPUF was less 
predictable (Table 3). Improvement of SPUF appeared to mark patients who recovered from UFF 
during follow-up (Table 5). 
 
Several longitudinal studies have analyzed the time course of peritoneal water transport in the PD 
population at large. Struijk et al. (11) reported a bimodal evolution of UF and small solute 
transport during the first 2 years on PD, with an increase in the UF capacity during the first 6 
months, followed by a decrease thereafter. As a consequence, UF rates after 2 years of follow-up 
were similar to baseline values. Davies (12) analyzed the results of classic PET in 574 patients 
incident on PD, observing an essential stability of the UF capacity during the first 12 months, 
followed by a progressive decay in the ensuing years. Small solute transport rates showed a 
simultaneous regression to mean values, increasing in slower transporters and decreasing in fast 
transporters. Similar findings were reported by Fernandez-Reyes et al. (13), with nonsignificant 
trends to an increase in UF during the first year, and a later progressive decay. A more recent in-
depth study (14), based on SPA tests, partially confirmed the results of previous investigations, by 
reporting an overall stability of the capacity of UF during the first years, followed by a later 
decline, particularly after the fourth year on PD. 
 
Few studies have attempted to characterize UFF present since the initiation of PD. During a 
longitudinal analysis, del Peso et al. (15) detected an increase of the capacity of UF and a decrease 
of small solute transport rates at the end of the first year in these patients. Only 2 out of 12 patients 
with incident UFF still suffered this condition after this period. This study, based on a specific 
kinetic software, did not investigate UF fractions. More recently, a cross-sectional, SPA-based 
analysis (16) compared patients with UFF, according to permanence on PD at the time of 
diagnosis, although incident patients with the condition were not assessed separately. Patients 
treated for less than 2 years with PD and suffering from UFF presented relatively fast small solute 
transport rates, rapid lymphatic absorption rates, decreased FWT, preserved SPUF, and similar 
hydraulic permeability and osmotic conductance to glucose, when compared with their controls 
without UFF. On the contrary, patients with late UFF presented a more diffuse disorder of UF 
fractions (affecting both FWT and SPUF) and decreased hydraulic permeability and osmotic 
conductance to glucose. For the authors, the changes observed in earlier UFF were consistent with 
a large number of perfused peritoneal vessels and a fast lymphatic absorption. Moreover, 
preserved osmotic conductance to glucose suggested that changes were, at least for the most part, 
functional and, consequently, potentially reversible. These changes have been suggested to follow 
the release of vasoactive substances by mesothelial cells, in response to contact with dialysate 
(17). These observations are consistent with current classification of UFF (18). According to the 
latter, early UFF could be secondary to either endothelial dysfunction (often related to an 
inflammatory state) or to a large peritoneal vascular surface area. The former subgroup could 
explain the poor prognosis associated with early UFF observed in some studies (19). On the other 
hand, changes observed in late UFF indicate a structural and irreversible injury to the peritoneal 
membrane, more consistently associated with decreased patient and technique survival rates (19). 
In our study, incident patients with UFF experienced a systematic increase of FWT and sodium 
sieving at 60 minutes after 1 year of follow-up, while SPUF rates remained unchanged for the 
whole subgroup (Table 3). Remarkably, these changes were not observed in incident patients with 
a normal capacity of UF at inception of PD. On the other hand, comparison between incident 
patients with UFF, according to recovery from this condition after 1 year (Table 5) suggested that 
FWT improved in both subgroups (although not to the same extent), while the more variable 
evolution of SPUF determined recovery, in practical terms. At first sight, the improvement of 
FWT could be attributed to a regression of the functional component of fast solute transport 
present at the initiation of PD. However, the increase in FWT was not systematically paralleled by 
an improvement in SPUF. The explanation for this discrepancy is not clear, but the consistent 
increase in FWT might be explained by an increase in aquaporin-driven UF, which could be a 
result of peritoneal exposure to dextrose-based solutions (20). On the other hand, changes 
observed for SPUF and small solute (particularly glucose) transport rates suggest an early increase 
in peritoneal vascular surface area, which was reversible in only a fraction of these patients. Our 
study was unable to identify factors which may portend reversibility of these disorders. In 
particular, baseline plasma levels of C-reactive protein or the rates of peritoneal infection during 
the first year were not discriminative for this purpose. Previous studies have disclosed associations 
among several genetic polymorphisms, on one hand, and both baseline small solute transport 
characteristics and their evolution in time, on the other (21). The relevance of genetic factors for 
the time course of incident UFF awaits further clarification. 
 
This study has significant weaknesses, including a limited statistical power. The longitudinal 
design offers clear advantages and a relatively novel approach, but has some drawbacks, including 
a risk for selective biases, due to a significant proportion of patients lost during follow-up. 
Moreover, the modified PET-based analysis did not permit direct estimations of lymphatic 
absorption rates, which demand specific methodologic approaches, beyond routine clinical 
practice (22). Despite these limitations, the study offers a longitudinal view of water transport in 
patients with UFF since the inception of PD, contributing to a clearer knowledge of this disorder. 
In summary, patients with UFF since the start of PD suffer a disorder of peritoneal water transport 
affecting both FWT and SPUF. Our data confirm that early UFF has a potential for reversibility, in 
many patients. Free water transport increases systematically in these patients after 1 year of 
follow-up, while the evolution of SPUF is less predictable. Improvement in SPUF marks patients 
in whom UFF is reversible. We did not detect consistent baseline markers that would serve to 
identify patients in whom UFF may be reversible. Peritoneal infections during the first year did not 
appear to influence the time course of water transport among incident patients with UFF. Further 
studies will be necessary to characterize early UFF in PD patients. 
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